This World Prematurity Day, FIGO calls on healthcare providers, policymakers, and communities to champion better care for ...
Each month FIGO shares news from throughout our 139 National Member Societies, notable highlights from our programme teams, and global advocacy activity.
The International Journal of Gynecology & Obstetrics (IJGO) has published a special article by the FIGO Committee on Ethical ...
We know this change is possible – we have recently witnessed France making history to enshrine the right to abortion in the ...
Affirming that improvements in women's health need more than better science and health care; they require state action to correct injustices to women. Recognising that women's health is often ...
May 2019, FIGO released Guidelines to combat pre-eclampsia, and calls for all women to receive first-trimester screening. Read the Pre-eclampsia Guidelines here. 76,000 women and 500,000 babies die ...
FIGO’s 2024-2025 free webinar series tackles the most pressing issues on women’s health and rights. Organised by FIGO’s Divisions and Committees, FIGO’s webinar series brings together women’s health ...
The project ended in India and Sri Lanka in December 2018, Nepal in June 2019, Kenya in September 2019, Tanzania in March 2020 and in Bangladesh in October 2020. Across 48 Referral Hospitals, the ...
Each member society is committed to supporting FIGO's aim for women of the world to achieve the highest possible standards of physical, mental, reproductive and sexual health and wellbeing throughout ...
The 2021 edition of the FIGO Cancer Report contains updates on the management of gynaecological cancers combined with pertinent papers on gynaecological oncology, which we hope the reader will find ...
FIGO’s strength comes from our world-renowned experts, whose knowledge and experience in all aspects of women’s health help shape best practice and innovation. Take a look at our latest resources and ...
The Committee on Menstrual Disorders and Related Health Impacts focuses on the set of symptoms described as non-gestational abnormal uterine bleeding (AUB), including heavy menstrual bleeding (HMB).